LAWRENCE, Mass.—NxStage Medical, Inc. commented on findings of the Chronic Disease Research Group (CDRG) study showing that patients receiving daily, or more frequent, home hemodialysis(HHD) with the NxStage System One are more likely to receive a kidney transplant when compared with conventional thrice-weekly dialysis, particularly in patients not on the transplant waitlist at initiation of daily HHD.
The study, "Transplant Rates in Frequent Hemodialysis and Matched Thrice-Weekly Hemodialysis Patients," was presented on Thursday, May 10 at the National Kidney Foundation (NKF) Spring Clinical Meeting in Washington, D.C.
The CDRG retrospective cohort study compared cumulative incidence of transplant in 1,873 daily HHD patients using the NxStage System One from 2005 to 2007 and a matched cohort of 9,365 thrice-weekly, in-center hemodialysis patients from the United States Renal Data System (USRDS) database. The study was designed using a unique, rigorous matching process with 17 covariates that could impact transplantation incidence, including demographics, comorbidity and socioeconomic status. Specifically, findings showed: